Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
BMC Medicine|February 17, 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesNurdan Guldiken, Josepmaria Argemi, Berivan Gurbuz, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2024
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver diseaseRohit Loomba, Ginger Clark, Jeff Teckman, et al.
Frontiers in Medicine|January 28, 2022
Liver Fibrosis-From Mechanisms of Injury to Modulation of DiseaseChristian Liedtke, Yulia A Nevzorova, Tom Luedde, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Gastroenterology|May 24, 2019
Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ MutationKarim Hamesch, Mattias Mandorfer, Vítor M Pereira, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological DiseasesSophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, et al.
Exploration of Digestive Diseases|April 9, 2026
Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and TreatmentIna Bergheim, Jean Francois Cadranel, Jian Guo Chen, et al.
Gastroenterology|October 16, 2024
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
Gastroenterology|December 13, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver DiseaseRohit Loomba, Virginia C Clark, Mattias Mandorfer, et al.
Pageof 21